List of Tables
Table 1. Solid Tumor Drug Market Trends
Table 2. Solid Tumor Drug Market Drivers & Opportunity
Table 3. Solid Tumor Drug Market Challenges
Table 4. Solid Tumor Drug Market Restraints
Table 5. Global Solid Tumor Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Solid Tumor Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Solid Tumor Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Solid Tumor Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Solid Tumor Drug
Table 10. Global Solid Tumor Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Solid Tumor Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Solid Tumor Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Solid Tumor Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Solid Tumor Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Solid Tumor Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Solid Tumor Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Solid Tumor Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Solid Tumor Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Solid Tumor Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Solid Tumor Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Solid Tumor Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Solid Tumor Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Solid Tumor Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Solid Tumor Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Solid Tumor Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Solid Tumor Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Solid Tumor Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Solid Tumor Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. AstraZeneca Basic Information List
Table 32. AstraZeneca Description and Business Overview
Table 33. AstraZeneca Solid Tumor Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Solid Tumor Drug Business of AstraZeneca (2019-2024)
Table 35. AstraZeneca Recent Developments
Table 36. Biogen Basic Information List
Table 37. Biogen Description and Business Overview
Table 38. Biogen Solid Tumor Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Solid Tumor Drug Business of Biogen (2019-2024)
Table 40. Biogen Recent Developments
Table 41. Baxter Basic Information List
Table 42. Baxter Description and Business Overview
Table 43. Baxter Solid Tumor Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Solid Tumor Drug Business of Baxter (2019-2024)
Table 45. Baxter Recent Developments
Table 46. Celgene Corporation Basic Information List
Table 47. Celgene Corporation Description and Business Overview
Table 48. Celgene Corporation Solid Tumor Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Solid Tumor Drug Business of Celgene Corporation (2019-2024)
Table 50. Celgene Corporation Recent Developments
Table 51. Abbott Laboratories Basic Information List
Table 52. Abbott Laboratories Description and Business Overview
Table 53. Abbott Laboratories Solid Tumor Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Solid Tumor Drug Business of Abbott Laboratories (2019-2024)
Table 55. Abbott Laboratories Recent Developments
Table 56. Pfizer Inc Basic Information List
Table 57. Pfizer Inc Description and Business Overview
Table 58. Pfizer Inc Solid Tumor Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Solid Tumor Drug Business of Pfizer Inc (2019-2024)
Table 60. Pfizer Inc Recent Developments
Table 61. Amgen Limited & Amgen Ireland Limited Basic Information List
Table 62. Amgen Limited & Amgen Ireland Limited Description and Business Overview
Table 63. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Solid Tumor Drug Business of Amgen Limited & Amgen Ireland Limited (2019-2024)
Table 65. Amgen Limited & Amgen Ireland Limited Recent Developments
Table 66. Bristol-Myers Squibb Company Basic Information List
Table 67. Bristol-Myers Squibb Company Description and Business Overview
Table 68. Bristol-Myers Squibb Company Solid Tumor Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Solid Tumor Drug Business of Bristol-Myers Squibb Company (2019-2024)
Table 70. Bristol-Myers Squibb Company Recent Developments
Table 71. GlaxoSmithKline plc. Basic Information List
Table 72. GlaxoSmithKline plc. Description and Business Overview
Table 73. GlaxoSmithKline plc. Solid Tumor Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Solid Tumor Drug Business of GlaxoSmithKline plc. (2019-2024)
Table 75. GlaxoSmithKline plc. Recent Developments
Table 76. F. Hoffmann-La Roche Ltd. Basic Information List
Table 77. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 78. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Solid Tumor Drug Business of F. Hoffmann-La Roche Ltd. (2019-2024)
Table 80. F. Hoffmann-La Roche Ltd. Recent Developments
Table 81. Eli Lilly and Company Basic Information List
Table 82. Eli Lilly and Company Description and Business Overview
Table 83. Eli Lilly and Company Solid Tumor Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Solid Tumor Drug Business of Eli Lilly and Company (2019-2024)
Table 85. Eli Lilly and Company Recent Developments
Table 86. Johnson & Johnson Basic Information List
Table 87. Johnson & Johnson Description and Business Overview
Table 88. Johnson & Johnson Solid Tumor Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Solid Tumor Drug Business of Johnson & Johnson (2019-2024)
Table 90. Johnson & Johnson Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Solid Tumor Drug Downstream Customers
Table 94. Solid Tumor Drug Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Solid Tumor Drug Product Picture
Figure 2. Global Solid Tumor Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Solid Tumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Solid Tumor Drug Report Years Considered
Figure 5. Global Solid Tumor Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Solid Tumor Drug Revenue in 2023
Figure 7. Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Small Molecules Picture
Figure 9. Biologics Picture
Figure 10. Global Solid Tumor Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Solid Tumor Drug Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Oncology
Figure 13. Product Picture of Neurology
Figure 14. Product Picture of Radiology
Figure 15. Product Picture of Others
Figure 16. Global Solid Tumor Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Solid Tumor Drug Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Solid Tumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Solid Tumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Solid Tumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Solid Tumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Solid Tumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Solid Tumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Solid Tumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Solid Tumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Solid Tumor Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Solid Tumor Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Solid Tumor Drug Sales Value (%), (2019-2030)
Figure 29. United States Solid Tumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Solid Tumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Solid Tumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Solid Tumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Solid Tumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Solid Tumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 35. China Solid Tumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Solid Tumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 37. China Solid Tumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Solid Tumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Solid Tumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Solid Tumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Solid Tumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Solid Tumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Solid Tumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Solid Tumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Solid Tumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Solid Tumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. India Solid Tumor Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Solid Tumor Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. India Solid Tumor Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. Solid Tumor Drug Industrial Chain
Figure 51. Solid Tumor Drug Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
